Liquid Biopsy and Expanding Access to Precision Oncology
NOW on demand, Part 2 of 3 Caris Life Sciences Series. Host Shahid Shah sits down with Joseph C. Murray, MD, PhD to continue the series with “The Access”.
Read MoreNOW on demand, Part 2 of 3 Caris Life Sciences Series. Host Shahid Shah sits down with Joseph C. Murray, MD, PhD to continue the series with “The Access”.
Read MoreNOW on demand, Part 1 of 3 Caris Life Sciences Series. Host Shahid Shah sits down with Dr. James Hamrick to start the series with, “The Science”.
By Houda Hachad – Cancer care is undergoing a structural transformation. Advances in early detection, targeted therapies, and immunotherapies have improved outcomes. According to the American Cancer Society, the five-year survival rate for all cancers combined has now reached 70%, reflecting meaningful progress in treatment and care delivery.
By Jim Foote – As cancer becomes the #1 killer of men and the #2 killer of women under 50, with two million new cancer diagnoses and more than 600,000 deaths projected for 2025, oncologists are racing to find tools that can transform biological complexity into clinical clarity.
From the Health IT Buzz Blog – Recognizing the importance of seamless data exchange in oncology, six health IT vendors have committed to supporting USCDI+ Cancer data elements (two more organizations pledged to promote cancer-related activities in their work), marking a significant step toward a more interoperable and standardized healthcare system.
By Morris Panner – Modern medicine has revolutionized cancer treatment, and the prognosis for many cancers today is very good if caught early. That’s why regular screenings for certain cancers are a crucial part of preventive care.
CMS issued the Calendar Year 2023 Physician Fee Schedule proposed rule, which would significantly expand access to behavioral health services, Accountable Care Organizations, cancer screening, and dental care – particularly in rural and underserved areas.
By Sarah Larsen – During the first year of the Covid pandemic, patients missed around 10M potentially life-saving cancer screenings. The CDC encourages health care professionals to minimize delays in testing by continuing routine cancer screening, and helping patients safely access screening through interventions such as navigation (both human and digital).
By Robert E. Winkler MD – COVID-19 vaccines were developed extremely fast, approximately nine months from pandemic emergence to FDA approval in the U.S. This is, by a landslide, a record for one of the fastest development (and approval) of a vaccine, and significantly faster than traditional R&D timelines.